The 22nd International Conference on Kaposi's sarcoma-associated herpesvirus and Related Agents

第22届卡波西肉瘤相关疱疹病毒及相关药物国际会议

基本信息

批准号：
9763269
负责人：
ETHEL CESARMAN
金额：
$ 0.8万
依托单位：
WEILL MEDICAL COLL OF CORNELL UNIV
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-04-09 至 2020-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9763269
关键词：
Academia Acquired Immunodeficiency Syndrome Anniversary Applications Grants Asia Biology Biotechnology Cancer Etiology Career Mobility Cessation of life Clinical Collaborations Country DNA Viruses Data Development Discipline Disease Educational workshop Epidemiology Europe Fees Foundations Funding Funding Mechanisms Gene Expression Goals Government HIV Herpesviridae Hour Human Human Herpesvirus 4 Human Herpesvirus 8 Immune response Industry Infection Institution International Kaposi Sarcoma Knowledge Lymphocryptovirus Macaca mulatta Malignant Neoplasms Mentors Mission Murine herpesvirus 68 Mus National Institute of Allergy and Infectious Disease National Institute of Dental and Craniofacial Research New York City North America Oncogenic Oral Pathogenesis Pharmacologic Substance Postdoctoral Fellow Prevention strategy Request for Applications Research Research Personnel Research Priority Rhadinovirus Saimiriine Herpesvirus 2 Site Therapeutic Intervention Time Underrepresented Minority United States National Institutes of Health Update Viral Viral Genes Viral Pathogenesis Virus Virus Latency cost expectation gammaherpesvirus human DNA human disease meetings minority scientist pathogen posters pre-doctoral research and development symposium treatment strategy vaccination strategy vaccine development

项目摘要

ABSTRACT This conference grant application requests funds to help support the 22nd International Conference on Kaposi's Sarcoma Herpesvirus and Related Agents in 2019. Our annual conference will bring together researchers and clinicians working on the oncogenic human herpesvirus, Kaposi's sarcoma herpesvirus (KSHV), and other closely related pathogens. The funds will be used to reduce the conference registration costs for outstanding US pre- and post- doctoral trainees, historically under-represented minorities, and scientists from poor countries who study oncogenic DNA viruses. The goals of these meetings are consistent with the mission statements of the NIH, NCI, NIAID, and NIDCR, namely, to advance and promote the pace of research on infections associated with human cancer and other diseases, including in the setting of HIV-AIDS. The KSHV conference will be held in New York City and will occur from the evening of June 30 through the morning of July 3, 2019. All remaining costs for these conferences will be raised from registration fees paid by the conferees and contributions from host institutions, foundations, and pharmaceutical and biotechnology companies. The main focus of the KSHV meeting is the biology of oncogenic herpesviruses and associated human diseases, with specific emphasis on viral pathogenesis, viral latency and reactivation, viral gene expression and replication, host responses to infection, epidemiology, vaccine development, and therapeutic intervention. In addition to KSHV, studies related to herpesvirus saimiri (HVS), murine herpesvirus-68 (MHV-68), and rhesus rhadinovirus (RRV) will be presented. The 22nd International Conference on Kaposi's Sarcoma-Associated Herpesvirus and Related Agents is the 25th anniversary of the virus's discovery. ! !

抽象的本次会议拨款申请请求资金来帮助支持第 22 届国际会议 2019年卡波西肉瘤疱疹病毒及相关病原体会议。我们的年度会议会议将汇集致力于人类致癌研究的研究人员和临床医生疱疹病毒、卡波西肉瘤疱疹病毒（KSHV）和其他密切相关的病原体。这资金将用于减少未完成的美国会前和会后的会议注册费用博士生、历来代表性不足的少数族裔以及来自贫穷国家的科学家研究致癌DNA病毒的人。这些会议的目标与使命一致 NIH、NCI、NIAID 和 NIDCR 的声明，即推进和促进与人类癌症和其他疾病相关的感染研究，包括在艾滋病毒/艾滋病的环境。 KSHV 会议将在纽约市举行，将于 2019 年 6 月 30 日晚上至 7 月 3 日上午。这些费用的所有剩余费用会议费用将从参会者缴纳的注册费和来自各方的捐款中筹集主办机构、基金会、制药和生物技术公司。主要 KSHV 会议的焦点是致癌性疱疹病毒及相关人类的生物学疾病，特别强调病毒发病机制、病毒潜伏期和重新激活、病毒基因表达和复制、宿主对感染的反应、流行病学、疫苗开发、和治疗干预。除了 KSHV 之外，还有与 saimiri 疱疹病毒 (HVS) 相关的研究，将展示鼠疱疹病毒 68 (MHV-68) 和恒河猴病毒 (RRV)。 22日卡波西肉瘤相关疱疹病毒及相关病原体国际会议病毒发现 25 周年。！！